Christopher Fuller
About Christopher Fuller
Christopher Fuller is a Pharmacy Manager with extensive experience in pharmacy practice and education. He has held various roles, including Clinical Pharmacist and Associate Professor at the University of Florida, and currently serves on the State of Florida Medicaid Pharmaceutical and Therapeutics Committee.
Work at Option Care Health
Christopher Fuller has been serving as the Pharmacy Manager at Option Care Health since 2020. In this role, he has been actively involved in re-imagining the infusion care therapy experience. His focus has been on enhancing patient care and optimizing pharmacy operations within the organization. His tenure at Option Care Health has allowed him to apply his extensive experience in pharmacy management to improve service delivery.
Education and Expertise
Christopher Fuller earned a Bachelor of Pharmacy (BSPharm) from Massachusetts College of Pharmacy and Health Sciences, where he studied from 1978 to 1983. He also completed coursework in Economics at North Shore Community College in 1977-1978. His educational background has equipped him with a strong foundation in pharmacy practice and medicinal chemistry, which he has utilized throughout his career in various clinical roles.
Background
Christopher Fuller has a diverse background in pharmacy practice, having worked in various capacities since the early 1980s. He served as a Clinical Pharmacist at the University of Florida for 28 years, contributing to the education of pharmacy students and the management of patient care. He also worked at Wells Pharmacy Network and Publix Super Markets, where he held the position of Pharmacy Manager for several years. His extensive experience spans both clinical and academic settings.
Achievements
Christopher Fuller has over two decades of experience in pharmacy education as an Associate Professor at the University of Florida, where he has contributed to the training of future pharmacists. He has been a member of the State of Florida Medicaid Pharmaceutical and Therapeutics Committee since 2017, where he plays a role in developing and evaluating pharmaceutical policies. His involvement in these committees reflects his commitment to improving healthcare practices in Florida.